Skip to content

Adaptive Biotechnologies ADPT Total Current Assets

Total Current Assets at other companies

Guardant Health logo
Guardant HealthGH
$1.37B+47.5%
Natera, Inc. logo
Natera, Inc.NTRA
$1.65B+16.6%
Monte Rosa Therapeutics, Inc. logo
Monte Rosa Therapeutics, Inc.GLUE
$677.55M+104%
Veracyte logo
VeracyteVCYT
$522.18M+36.3%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$554.39M-1.7%
GeneDx Holdings logo
GeneDx HoldingsWGS

Other financials

Income statement

See full
Revenue$70.9M+35.1%
Gross profit$52.2M+47.1%
Operating income-$19.2M+35.1%
Net income-$20.0M+32.9%
EPS (diluted)-$0.13+35.0%

Balance sheet

See full
Cash & equivalents$77.6M+53.2%
Total debt$208.2M-5.6%
Total equity$216.3M+13.6%
Total assets$505.9M-1.0%

Cash flow

See full
Operating cash flow-$9.5M+66.5%
CapEx$796.0K-36.8%
Free cash flow-$10.3M+65.3%

Valuation

See full
Market cap$2.76B+93.6%
Enterprise value$2.89B+78.0%
P/S9.3×+1.8×

Profitability

See full
Gross margin75.3%+12.7pp
Operating margin-15.8%-7.0pp
Net margin-16.8%-7.3pp
FCF margin-10.5%-4.6pp

Returns & leverage

See full
Return on equity-24.4%-9.2pp
Debt / equity-0.2×
Current ratio3.4×+0.4×

Where this comes from

Reported directly by Adaptive Biotechnologies in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Adaptive Biotechnologies's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Adaptive Biotechnologies's total current assets?
Adaptive Biotechnologies (ADPT) reported total current assets of $291.81M in Q1 2026.
How has Adaptive Biotechnologies's total current assets changed year-over-year?
Adaptive Biotechnologies's total current assets increased by 13.8% year-over-year, from $256.49M to $291.81M.
What is the long-term trend for Adaptive Biotechnologies's total current assets?
Over 5 years (2020 to 2025), Adaptive Biotechnologies's total current assets has grown at a -16.2% compound annual growth rate (CAGR), from $726.91M to $300.19M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.